Literature DB >> 25162776

Anxiety and Depression Are Better Correlates of Parkinson's Disease Quality of Life Than Apathy.

Jacob D Jones1, London C Butterfield1, Woojin Song1, Jacob Lafo1, Paul Mangal1, Michael S Okun1, Dawn Bowers1.   

Abstract

Due to controversy regarding the influence of apathy on quality of life (QoL), the authors examined the independent influence of apathy, depression, and trait anxiety in a nondemented sample of patients with Parkinson disease (PD). Participants (N=107) completed standard self-report measures of QoL and mood/motivation. Analyses investigated the contribution of these measures and empirically derived factor scores on QoL. QoL was predicted by trait anxiety, dysphoria, and decreased interest, with no independent contribution of apathy. Different patterns emerged with respect to domain-specific QoL, with trait anxiety being the strongest predictor across most domains. Anxiety was most widely related to QoL in PD, with minimal contribution of apathy. Future studies should examine different roles of PD mood/motivation symptoms on caregiver QoL.

Entities:  

Mesh:

Year:  2014        PMID: 25162776      PMCID: PMC4344415          DOI: 10.1176/appi.neuropsych.13120380

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  35 in total

1.  Characterization of apathy in persons with frontotemporal dementia and the impact on family caregivers.

Authors:  Jennifer Merrilees; Glenna A Dowling; Erin Hubbard; Judy Mastick; Robin Ketelle; Bruce L Miller
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jan-Mar       Impact factor: 2.703

2.  Do motor and nonmotor symptoms in PD patients predict caregiver strain and depression?

Authors:  Julie H Carter; Barbara J Stewart; Karen S Lyons; Patricia G Archbold
Journal:  Mov Disord       Date:  2008-07-15       Impact factor: 10.338

3.  The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease.

Authors:  A F Leentjens; F R Verhey; G J Luijckx; J Troost
Journal:  Mov Disord       Date:  2000-11       Impact factor: 10.338

4.  How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population.

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  Mov Disord       Date:  2000-11       Impact factor: 10.338

5.  Dissociating apathy and depression in Parkinson disease.

Authors:  L Kirsch-Darrow; H H Fernandez; H F Fernandez; M Marsiske; M S Okun; D Bowers
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease.

Authors:  Valeria Isella; Paola Melzi; Marco Grimaldi; Simona Iurlaro; Roberto Piolti; Carlo Ferrarese; Lodovico Frattola; Ildebrando Appollonio
Journal:  Mov Disord       Date:  2002-03       Impact factor: 10.338

8.  Predictors of caregiver burden in partners of patients with Parkinson's disease.

Authors:  Marco D'Amelio; Valeria Terruso; Barbara Palmeri; Norma Di Benedetto; Giorgia Famoso; Paolo Cottone; Paolo Aridon; Paolo Ragonese; Giovanni Savettieri
Journal:  Neurol Sci       Date:  2009-02-03       Impact factor: 3.307

9.  Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimer's disease (AD).

Authors:  Monica Ricci; Silvia Vittoria Guidoni; Micaela Sepe-Monti; Giuseppe Bomboi; Giovanni Antonini; Carlo Blundo; Franco Giubilei
Journal:  Arch Gerontol Geriatr       Date:  2008-12-11       Impact factor: 3.250

10.  A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia.

Authors:  A McKinlay; R C Grace; J C Dalrymple-Alford; T Anderson; J Fink; D Roger
Journal:  Parkinsonism Relat Disord       Date:  2007-07-12       Impact factor: 4.891

View more
  15 in total

1.  Latent growth-curve analysis reveals that worsening Parkinson's disease quality of life is driven by depression.

Authors:  Jacob D Jones; Michael Marsiske; Michael S Okun; Dawn Bowers
Journal:  Neuropsychology       Date:  2014-11-03       Impact factor: 3.295

2.  Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.

Authors:  Jacob D Jones; Natalie E Kurniadi; Taylor P Kuhn; Sarah M Szymkowicz; Joseph Bunch; Elizabeth Rahmani
Journal:  Neuropsychology       Date:  2019-07-25       Impact factor: 3.295

3.  Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson's Disease.

Authors:  Sarah M Szymkowicz; Vonetta M Dotson; Jacob D Jones; Michael S Okun; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2017-10-16       Impact factor: 2.892

4.  Mood Differences Among Parkinson's Disease Patients With Mild Cognitive Impairment.

Authors:  Jacob D Jones; Paul Mangal; Jacob Lafo; Michael S Okun; Dawn Bowers
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2016-01-21       Impact factor: 2.198

5.  Changes in cognition precede changes in HRQoL among HIV+ males: Longitudinal analysis of the multicenter AIDS cohort study.

Authors:  Jacob D Jones; Taylor Kuhn; Andrew Levine; Ned Sacktor; Cynthia A Munro; Linda A Teplin; Gypsyamber D'Souza; Eileen M Martin; James T Becker; Eric N Miller; Charles H Hinkin
Journal:  Neuropsychology       Date:  2019-03       Impact factor: 3.424

6.  Sertraline plus deanxit to treat patients with depression and anxiety in chronic somatic diseases: a randomized controlled trial.

Authors:  Limin Wang; Zhuoyuan Zhong; Jingyang Hu; Xiaoming Rong; Jun Liu; Songhua Xiao; Zhonglin Liu
Journal:  BMC Psychiatry       Date:  2015-04-14       Impact factor: 3.630

7.  Cognitive Function in Parkinson's Disease Patients with and without Anxiety.

Authors:  K A Ehgoetz Martens; J Y Y Szeto; A J Muller; J M Hall; M Gilat; C C Walton; S J G Lewis
Journal:  Neurol Res Int       Date:  2016-10-09

8.  Evaluation of PDQ-8 and its relationship with PDQ-39 in China: a three-year longitudinal study.

Authors:  Kui Chen; Yu-Jie Yang; Feng-Tao Liu; Da-Ke Li; Lu-Lu Bu; Ke Yang; Ying Wang; Bo Shen; Rong-Yuan Guan; Jie Song; Jian Wang; Jian-Jun Wu
Journal:  Health Qual Life Outcomes       Date:  2017-08-24       Impact factor: 3.186

9.  Heterogeneous Determinants of Quality of Life in Different Phenotypes of Parkinson's Disease.

Authors:  Seyed-Mohammad Fereshtehnejad; Mahdiyeh Shafieesabet; Farzaneh Farhadi; Hasti Hadizadeh; Arash Rahmani; Nader Naderi; Dena Khaefpanah; Gholam Ali Shahidi; Ahmad Delbari; Johan Lökk
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

10.  Clinical Profile of Chinese Long-Term Parkinson's Disease Survivors With 10 Years of Disease Duration and Beyond.

Authors:  Qian Sun; Tian Wang; Tian-Fang Jiang; Pei Huang; Ying Wang; Qin Xiao; Jun Liu; Sheng-Di Chen
Journal:  Aging Dis       Date:  2018-02-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.